DOTA-[Tyr3]-Octreotate
DOTA-[Tyr3]-Octreotate
from $413.00
DOTA-[Tyr3]-Octreotate, DTPA-TATE |
DOTA-fCYwKTCT-OH (Disulfide bridge: 2-7) |
DOTA-Octreotates are a group of compounds comprising DOTA, a metal chelator that carries a radionuclide and octreotide (an octapeptide that is a potent somatostatin (SST)) analog (where DOTA is tetra-aza-cyclododecane-N N’N’’N-’’’-tetra-acetate). Replacement of Phe by Tyr has been shown to increase affinity of DOTA-Octreotate radioconjugates to SST2-positive tumors both in-vitro and in-vivo. This form also has moderately high affinity for SST5 and intermediate affinity for SST3. Studies have shown therapeutic benefits including antimitotic effects and symptomatic cure of malignant insulinomas and gastrinomas. |
Cat No: | CP4005 |
Peptide Sequence | DOTA - D - Phe - Cys - Tyr - D - Trp - Lys - Thr - Cys - Thr - OH (Disulfide bridge: 2 - 7) |
Molecular mass | 1435.6 |
Protect from Light | Yes |
Packaged under inert gas | Yes |
Purity | ≥95% by HPLC |
Solubility | H2O |
Storage | -20°C |
Title:
Quantity: